Rupali Bank PLC. (DSE:RUPALIBANK)

Intra-Cellular Therapies Revenue

Rupali Bank PLC. had revenue of 3.15B BDT in the quarter ending June 30, 2025, a decrease of -18.36%. This brings the company's revenue in the last twelve months to 11.63B, down -13.97% year-over-year. In the year 2024, Rupali Bank PLC. had annual revenue of 12.52B, down -6.37%.

• Revenue (ttm): 11.63B
• Revenue Growth: -13.97%
• P/S Ratio: 1.01
• Revenue / Employee: 1.96M
• Employees: 5,935
• Market Cap: 11.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	12.52B	-851.77M	-6.37%
Dec 31, 2023	13.37B	-1.58B	-10.56%
Dec 31, 2022	14.95B	1.63B	12.22%
Dec 31, 2021	13.32B	2.37B	21.61%
Dec 31, 2020	10.95B	387.23M	3.66%